OUTSOURCING OF RESEARCH AND DEVELOPMENT ACTIVITIES: EVIDENCE FROM U.S. BIOPHARMACEUTICAL FIRMS

Arup K. Sen

Global Journal of Business Research, 2009, vol. 3, issue 1, 73-82

Abstract: This paper examines changes in outsourcing in biopharmaceutical firms over the past ten years using a survey of 86 firms. The data suggest that in spite of the rising expenses in research and development (R&D) and the trend toward external sourcing, a large segment of the firms still prefer to conduct discovery and research in-house. Despite a growing literature on the importance of R&D outsourcing in the biopharmaceutical industry, the data suggest that most firms have recently been reducing their dependence on external R&D partners. The results indicate that the biopharmaceutical firms are using a combination of domestic and foreign firms to outsource their R&D activities and there is no correlation between outsourcing and R&D intensity. The paper concludes with a brief discussion of the implications of the survey findings and the role outsourcing play for R&D activities in the biopharmaceutical industry.

JEL-codes: M16 (search for similar items in EconPapers)
Date: 2009
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
http://www.theibfr2.com/RePEc/ibf/gjbres/gjbr-v3n1-2009/GJBR-V3N1-2009-7.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ibf:gjbres:v:3:y:2009:i:1:p:73-82

Access Statistics for this article

Global Journal of Business Research is currently edited by Terrance Jalbert

More articles in Global Journal of Business Research from The Institute for Business and Finance Research
Bibliographic data for series maintained by Mercedes Jalbert ( this e-mail address is bad, please contact ).